AMD – UK slow to use innovative medicines

AMD – The UK’s continued use of older medicines means the country is behind most of its peers in the use of innovative new medicines, including those for wet age-related macular degeneration.

More… www.pharmatimes.com/Article/14-12-01/UK_still_low_in_the_league_table_for_new_meds_uptake.aspx#ixzz3KjiAPInb